Abstract
Hepatitis B virus (HBV) chronically infects an estimated 240 million people worldwide and is a major health problem. Despite its DNA genome, the virus is characterised by a high degree of genetic heterogeneity because of the use of an RNA intermediate and a reverse transcriptase during replication. Under the pressure of the immune response or exogenous factors such as immunisation or antiviral drugs, clinically relevant mutations in different proteins can be selected. Until now, HBV isolates have been classified in nine main genotypes (A–I), further segregated into subgenotypes, which have distinct ethno-geographic distributions. Genotypes A and D are ubiquitous and the two most prevalent genotypes in Europe, whereas genotypes B and C are restricted to eastern Asia and Oceania, genotype E to central and western Africa, and genotypes H and F to Latin America and Alaska. This review summarises the data concerning the origin and dispersion histories of the main HBV genotypes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9. doi:10.1016/j.vaccine.2011.12.116.
Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe—a review. Euro Surveill. 2008;13(21).
Schaefer S. Hepatitis B virus genotypes in Europe. Hepatol Res. 2007;37(s1):S20–6. doi:10.1111/j.1872-034X.2007.00099.x.
He B, Fan Q, Yang F, Hu T, Qiu W, Feng Y, Li Z, Li Y, Zhang F, Guo H, Zou X, Tu C. Hepatitis virus in long-fingered bats, Myanmar. Emerg Infect Dis. 2013;19(4):638–40. doi:10.3201/eid1904.121655.
Prince AM, Ikram H, Hopp TP. Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A. 1982;79(2):579–82.
Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol. 1994;68(3):2026–30.
Tian Y, Yang W, Song J, Wu Y, Ni B. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol. 2013;33(15):2810–6. doi:10.1128/mcb.00205-13.
Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol. 2005;42(3):302–8. doi:10.1016/j.jhep.2004.12.015.
Mizokami M, Orito E, Ohba K, Ikeo K, Lau JY, Gojobori T. Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol. 1997;44 Suppl 1:S83–90.
Deny P, Zoulim F. Hepatitis B virus: from diagnosis to treatment. Pathol Biol. 2010;58(4):245–53. doi:10.1016/j.patbio.2010.05.002.
Harrison TJ. Hepatitis B virus: molecular virology and common mutants. Semin Liver Dis. 2006;26(2):87–96. doi:10.1055/s-2006-939754.
Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis. 2004;24 Suppl 1:3–10. doi:10.1055/s-2004-828672.
Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989;2(8663):588–91.
Laskus T, Rakela J, Nowicki MJ, Persing DH. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology. 1995;109(5):1618–23.
Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med. 1991;324(24):1705–9. doi:10.1056/nejm199106133242405.
Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991;324(24):1699–704. doi:10.1056/nejm199106133242404.
Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology. 1993;105(4):1173–8.
Liang TJ, Hasegawa K, Munoz SJ, Shapiro CN, Yoffe B, McMahon BJ, Feng C, Bei H, Alter MJ, Dienstag JL. Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest. 1994;93(2):550–5. doi:10.1172/jci117006.
Blum HE, Galun E, Liang TJ, von Weizsacker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol. 1991;65(4):1836–42.
Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582–92. doi:10.1016/s0140-6736(09)60207-5.
Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology. 1998;27(6):1670–7. doi:10.1002/hep.510270628.
Locarnini SA, Yuen L. Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther. 2010;15(3 Pt B):451–61. doi:10.3851/imp1499.
Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol. 2002;25(2):97–106.
Raimondo G, Costantino L, Caccamo G, Pollicino T, Squadrito G, Cacciola I, Brancatelli S. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J Hepatol. 2004;40(3):515–9. doi:10.1016/j.jhep.2003.11.025.
Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, Zuckerman AJ. Hepatitis B variant in Europe. Lancet. 1988;2(8620):1132–3.
Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J Infect Dis. 1997;175(3):511–23.
Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol. 1999;59(1):19–24.
Mimms L. Hepatitis B virus escape mutants: “pushing the envelope” of chronic hepatitis B virus infection. Hepatology. 1995;21(3):884–7.
Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336(8711):325–9.
Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol. 1991;13 Suppl 4:S105–7.
Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology. 1997;26(3):786–91. doi:10.1002/hep.510260336.
Zuckerman AJ, Harrison TJ, Oon CJ. Mutations in S region of hepatitis B virus. Lancet. 1994;343(8899):737–8.
Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis. 1994;169(6):1374–6.
Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology. 1998;28(2):555–61. doi:10.1002/hep.510280237.
Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine. 2004;22(21–22):2791–9. doi:10.1016/j.vaccine.2004.01.046.
Ogata N, Cote PJ, Zanetti AR, Miller RH, Shapiro M, Gerin J, Purcell RH. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology. 1999;30(3):779–86. doi:10.1002/hep.510300309.
Purcell RH. Hepatitis B virus mutants and efficacy of vaccination. Lancet. 2000;356(9231):769–70. doi:10.1016/s0140-6736(05)73670-9.
Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis. 2001;184(7):905–8. doi:10.1086/323396.
El Chaar M, Candotti D, Crowther RA, Allain JP. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology. 2010;52(5):1600–10. doi:10.1002/hep.23886.
Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47(6):289–309. doi:10.1159/000080872.
Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81(Pt 1):67–74.
Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002;83(Pt 8):2059–73.
Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, Chen QR, Zhang J, Chen PJ, Xia NS. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype “I”. PLoS One. 2010;5(2):e9297. doi:10.1371/journal.pone.0009297.
Arankalle VA, Gandhe SS, Borkakoty BJ, Walimbe AM, Biswas D, Mahanta J. A novel HBV recombinant (genotype I) similar to Vietnam/Laos in a primitive tribe in eastern India. J Viral Hepat. 2010;17(7):501–10. doi:10.1111/j.1365-2893.2009.01206.x.
Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP. Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis. 2008;14(11):1777–80. doi:10.3201/eid1411.080437.
Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol. 2008;82(11):5657–63. doi:10.1128/jvi.02556-07.
Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009;83(20):10538–47. doi:10.1128/jvi.00462-09.
Bollyky P, Rambaut A, Grassly N, Carman W, Holmes E. Hepatitis B virus has a recent new world evolutionary origin. Hepatology. 1997;4:765. WB Saunders Co., Independence Square West Curtis Center, Ste 300, Philadelphia, PA 19106-3399.
MacDonald DM, Holmes EC, Lewis JC, Simmonds P. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J Virol. 2000;74(9):4253–7.
Fares MA, Holmes EC. A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol. 2002;54(6):807–14. doi:10.1007/s00239-001-0084-z.
Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M, Gojobori T. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci U S A. 1989;86(18):7059–62.
Zehender G, De Maddalena C, Giambelli C, Milazzo L, Schiavini M, Bruno R, Tanzi E, Galli M. Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. Virology. 2008;380(1):84–90. doi:10.1016/j.virol.2008.07.009.
Holmes EC. Evolutionary history and phylogeography of human viruses. Annu Rev Microbiol. 2008;62:307–28. doi:10.1146/annurev.micro.62.081307.162912.
Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP, Hatzakis A. Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology. 2013;57(3):908–16. doi:10.1002/hep.26079.
Devesa M, Pujol FH. Hepatitis B virus genetic diversity in Latin America. Virus Res. 2007;127(2):177–84. doi:10.1016/j.virusres.2007.01.004.
Braga WS. [Hepatitis B and D virus infection within Amerindians ethnic groups in the Brazilian Amazon: epidemiological aspects]. Rev Soc Bras Med Trop. 2004;37 Suppl 2:9–13.
Echevarria JM, Leon P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica. 2003;19(6):1583–91.
Tamm E, Kivisild T, Reidla M, Metspalu M, Smith DG, Mulligan CJ, Bravi CM, Rickards O, Martinez-Labarga C, Khusnutdinova EK, Fedorova SA, Golubenko MV, Stepanov VA, Gubina MA, Zhadanov SI, Ossipova LP, Damba L, Voevoda MI, Dipierri JE, Villems R, Malhi RS. Beringian standstill and spread of Native American founders. PLoS One. 2007;2(9):e829. doi:10.1371/journal.pone.0000829.
Kitchen A, Miyamoto MM, Mulligan CJ. A three-stage colonization model for the peopling of the Americas. PLoS One. 2008;3(2):e1596. doi:10.1371/journal.pone.0001596.
Goebel T, Waters MR, O’Rourke DH. The late Pleistocene dispersal of modern humans in the Americas. Science. 2008;319(5869):1497–502. doi:10.1126/science.1153569.
Murhekar MV, Chakravarty R, Murhekar KM, Banerjee A, Sehgal SC. Hepatitis B virus genotypes among the Jarawas: a primitive Negrito tribe of Andaman and Nicobar Islands, India. Arch Virol. 2006;151(8):1499–510. doi:10.1007/s00705-006-0737-8.
Kahila Bar-Gal G, Kim MJ, Klein A, Shin DH, Oh CS, Kim JW, Kim TH, Kim SB, Grant PR, Pappo O, Spigelman M, Shouval D. Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology. 2012;56(5):1671–80. doi:10.1002/hep.25852.
Harrison A, Lemey P, Hurles M, Moyes C, Horn S, Pryor J, Malani J, Supuri M, Masta A, Teriboriki B, Toatu T, Penny D, Rambaut A, Shapiro B. Genomic analysis of hepatitis B virus reveals antigen state and genotype as sources of evolutionary rate variation. Viruses. 2011;3(2):83–101. doi:10.3390/v3020083.
Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011;55(1):183–91. doi:10.1016/j.jhep.2010.12.030.
Kretzschmar M, de Wit GA, Smits LJ, van de Laar MJ. Vaccination against hepatitis B in low endemic countries. Epidemiol Infect. 2002;128(2):229–44.
Zehender G, Shkjezi R, Ebranati E, Gabanelli E, Abazaj Z, Tanzi E, Kraja D, Bino S, Ciccozzi M, Galli M. Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect Genet Evol. 2012;12(2):291–8. doi:10.1016/j.meegid.2011.11.009.
Murhekar MV, Murhekar KM, Sehgal SC. Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg. 2008;102(8):729–34. doi:10.1016/j.trstmh.2008.04.044.
Bozdayi G, Turkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol. 2005;76(4):476–81. doi:10.1002/jmv.20386.
Garmiri P, Rezvan H, Abolghasemi H, Allain JP. Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol. 2011;83(6):948–52. doi:10.1002/jmv.21772.
Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H. D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol. 2008;89(Pt 8):1829–39. doi:10.1099/vir.0.83660-0.
Zehender G, Ebranati E, Bernini F, Lo Presti A, Rezza G, Delogu M, Galli M, Ciccozzi M. Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. Infect Genet Evol. 2011;11(3):646–53. doi:10.1016/j.meegid.2011.02.003.
De Maddalena C, Giambelli C, Tanzi E, Colzani D, Schiavini M, Milazzo L, Bernini F, Ebranati E, Cargnel A, Bruno R, Galli M, Zehender G. High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus. Virology. 2007;365(1):113–24. doi:10.1016/j.virol.2007.03.015.
Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol. 2007;152(11):2017–25. doi:10.1007/s00705-007-1031-0.
Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol. 2006;78(9):1164–74. doi:10.1002/jmv.20677.
Lusida MI, Nugrahaputra VE, Soetjipto, Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H (2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol. 46(7):2160–6. doi:10.1128/jcm.01681-07.
Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, Benazzouz M, Rebbani K, Brahim I, Salih Alj H, Zoulim F, Trepo C, Chemin I, Ezzikouri S, Benjelloun S. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect. 2011;63(1):66–75. doi:10.1016/j.jinf.2011.05.007.
Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol. 2009;90(Pt 7):1622–8. doi:10.1099/vir.0.009738-0.
Abdou Chekaraou M, Brichler S, Mansour W, Le Gal F, Garba A, Deny P, Gordien E. A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains. J Gen Virol. 2010;91(Pt 6):1609–20. doi:10.1099/vir.0.018127-0.
Ghosh S, Banerjee P, Deny P, Mondal RK, Nandi M, Roychoudhury A, Das K, Banerjee S, Santra A, Zoulim F, Chowdhury A, Datta S. New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India. J Viral Hepat. 2013;20(3):209–18. doi:10.1111/j.1365-2893.2012.01655.x.
Michitaka K, Tanaka Y, Horiike N, Duong TN, Chen Y, Matsuura K, Hiasa Y, Mizokami M, Onji M. Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol. 2006;78(1):44–52. doi:10.1002/jmv.20502.
Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358(9297):1989–92. doi:10.1016/s0140-6736(01)06967-7.
Gerlich WH, Caspari G. Hepatitis viruses and the safety of blood donations. J Viral Hepat. 1999;6 Suppl 1:6–15.
Zehender G, De Maddalena C, Milazzo L, Piazza M, Galli M, Tanzi E, Bruno R. Hepatitis B virus genotype distribution in HIV-1 coinfected patients. Gastroenterology. 2003;125(5):1559–60. author reply 1660.
Pourkarim MR, Amini-Bavil-Olyaee S, Lemey P, Maes P, Van Ranst M. Are hepatitis B virus “subgenotypes” defined accurately? J Clin Virol. 2010;47(4):356–60. doi:10.1016/j.jcv.2010.01.015.
Coppola N, Masiello A, Tonziello G, Pisapia R, Pisaturo M, Sagnelli C, Messina V, Iodice V, Sagnelli E. Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J Viral Hepat. 2010;17(7):493–500. doi:10.1111/j.1365-2893.2009.01201.x.
Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005;294(2):194–201. doi:10.1001/jama.294.2.194.
Zehender G, Ebranati E, Gabanelli E, Shkjezi R, Lai A, Sorrentino C, Lo Presti A, Basho M, Bruno R, Tanzi E, Bino S, Ciccozzi M, Galli M. Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS One. 2012;7(5):e37198. doi:10.1371/journal.pone.0037198.
Mortimer PP. Arsphenamine jaundice and the recognition of instrument-borne virus infection. Genitourin Med. 1995;71(2):109–19.
Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403–6.
Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158–68.
Bowyer SM, van Staden L, Kew MC, Sim JG. A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol. 1997;78(Pt 7):1719–29.
Kramvis A, Weitzmann L, Owiredu WK, Kew MC. Analysis of the complete genome of subgroup A′ hepatitis B virus isolates from South Africa. J Gen Virol. 2002;83(Pt 4):835–9.
Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, Khan M, Gish RG, Tanaka Y, Kato T, Orito E, Ueda R, Miyakawa Y, Mizokami M. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol. 2004;85(Pt 4):811–20.
Kimbi GC, Kramvis A, Kew MC. Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol. 2004;85(Pt 5):1211–20.
Hannoun C, Soderstrom A, Norkrans G, Lindh M. Phylogeny of African complete genomes reveals a West African genotype A subtype of hepatitis B virus and relatedness between Somali and Asian A1 sequences. J Gen Virol. 2005;86(Pt 8):2163–7. doi:10.1099/vir.0.80972-0.
Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, Zekeng L, Ndembi N, Ngansop C, Kaptue L, Miura T, Ido E, Hayami M, Ichimura H, Mizokami M. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol. 2005;86(Pt 7):2047–56. doi:10.1099/vir.0.80922-0.
Makuwa M, Souquiere S, Telfer P, Apetrei C, Vray M, Bedjabaga I, Mouinga-Ondeme A, Onanga R, Marx PA, Kazanji M, Roques P, Simon F. Identification of hepatitis B virus subgenotype A3 in rural Gabon. J Med Virol. 2006;78(9):1175–84. doi:10.1002/jmv.20678.
Olinger CM, Venard V, Njayou M, Oyefolu AO, Maiga I, Kemp AJ, Omilabu SA, le Faou A, Muller CP. Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol. 2006;87(Pt 5):1163–73. doi:10.1099/vir.0.81614-0.
Hubschen JM, Mbah PO, Forbi JC, Otegbayo JA, Olinger CM, Charpentier E, Muller CP. Detection of a new subgenotype of hepatitis B virus genotype A in Cameroon but not in neighbouring Nigeria. Clin Microbiol Infect. 2011;17(1):88–94. doi:10.1111/j.1469-0691.2010.03205.x.
Pourkarim MR, Amini-Bavil-Olyaee S, Lemey P, Maes P, Van Ranst M. HBV subgenotype misclassification expands quasi-subgenotype A3. Clin Microbiol Infect. 2011;17(6):947–9. doi:10.1111/j.1469-0691.2010.03374.x.
Fujisaki S, Yokomaku Y, Shiino T, Koibuchi T, Hattori J, Ibe S, Iwatani Y, Iwamoto A, Shirasaka T, Hamaguchi M, Sugiura W. Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan. J Clin Microbiol. 2011;49(3):1017–24. doi:10.1128/jcm.02149-10.
van Houdt R, Bruisten SM, Geskus RB, Bakker M, Wolthers KC, Prins M, Coutinho RA. Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J Viral Hepat. 2010;17(2):108–14. doi:10.1111/j.1365-2893.2009.01158.x.
Hahne S, van Houdt R, Koedijk F, van Ballegooijen M, Cremer J, Bruisten S, Coutinho R, Boot H. Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands. PLoS One. 2013;8(7):e67866. doi:10.1371/journal.pone.0067866.
Kramvis A, Paraskevis D. Subgenotype A1 of HBV—tracing human migrations in and out of Africa. Antivir Ther. 2013;18(3 Pt B):513–21. doi:10.3851/imp2657.
Andernach IE, Nolte C, Pape JW, Muller CP. Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa. Emerg Infect Dis. 2009;15(8):1222–8. doi:10.3201/eid1508.081642.
Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum JJ, Nebie YK, Maiga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis. 2004;190(2):400–8. doi:10.1086/421502.
Andernach IE, Hubschen JM, Muller CP. Hepatitis B virus: the genotype E puzzle. Rev Med Virol. 2009;19(4):231–40. doi:10.1002/rmv.618.
Forbi JC, Vaughan G, Purdy MA, Campo DS, Xia GL, Ganova-Raeva LM, Ramachandran S, Thai H, Khudyakov YE. Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS One. 2010;5(7):e11615. doi:10.1371/journal.pone.0011615.
Mello FC, Souto FJ, Nabuco LC, Villela-Nogueira CA, Coelho HS, Franz HC, Saraiva JC, Virgolino HA, Motta-Castro AR, Melo MM, Martins RM, Gomes SA. Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates. BMC Microbiol. 2007;7:103. doi:10.1186/1471-2180-7-103.
Castilho Mda C, Oliveira CM, Gimaque JB, Leao JD, Braga WS. Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon. Am J Trop Med Hyg. 2012;87(4):768–74. doi:10.4269/ajtmh.2012.12-0083.
Alvarado-Mora MV, Pinho JR. Distribution of HBV genotypes in Latin America. Antivir Ther. 2013;18(3 Pt B):459–65. doi:10.3851/imp2599.
Venegas M, Alvarado-Mora MV, Villanueva RA, Rebello Pinho JR, Carrilho FJ, Locarnini S, Yuen L, Brahm J. Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection. J Med Virol. 2011;83(9):1530–6. doi:10.1002/jmv.22129.
Torres C, Pineiro y Leone FG, Pezzano SC, Mbayed VA, Campos RH. New perspectives on the evolutionary history of hepatitis B virus genotype F. Mol Phylogenet Evol. 2011;59(1):114–22. doi:10.1016/j.ympev.2011.01.010.
Panduro A, Maldonado-Gonzalez M, Fierro NA, Roman S. Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther. 2013;18(3 Pt B):475–84. doi:10.3851/imp2605.
Godoy BA, Alvarado-Mora MV, Gomes-Gouvea MS, Pinho JR, Fagundes Jr N. Origin of HBV and its arrival in the Americas—the importance of natural selection on time estimates. Antivir Ther. 2013;18(3 Pt B):505–12. doi:10.3851/imp2600.
Shi W, Zhang Z, Ling C, Zheng W, Zhu C, Carr MJ, Higgins DG. Hepatitis B virus subgenotyping: history, effects of recombination, misclassifications, and corrections. Infect Genet Evol. 2013;16:355–61. doi:10.1016/j.meegid.2013.03.021.
Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57(3–4):141–50. doi:10.1159/000360947.
Kato H, Orito E, Gish RG, Bzowej N, Newsom M, Sugauchi F, Suzuki S, Ueda R, Miyakawa Y, Mizokami M. Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology. 2002;35(4):922–9. doi:10.1053/jhep.2002.32096.
Bottecchia M, Souto FJ, O KM, Amendola M, Brandao CE, Niel C, Gomes SA. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil. BMC Microbiol. 2008;8:11. doi:10.1186/1471-2180-8-11.
Kim BK, Revill PA, Ahn SH. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther. 2011;16(8):1169–86. doi:10.3851/imp1982.
Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011;26 Suppl 1:123–30. doi:10.1111/j.1440-1746.2010.06541.x.
Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology. 2002;123(6):1848–56. doi:10.1053/gast.2002.37041.
Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100(16):1134–43. doi:10.1093/jnci/djn243.
Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking Sub-Saharan Africans. J Med Virol. 2005;75(4):513–21. doi:10.1002/jmv.20311.
Warner N, Locarnini S. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology. 2008;48(1):88–98. doi:10.1002/hep.22295.
Araujo NM, Waizbort R, Kay A. Hepatitis B virus infection from an evolutionary point of view: how viral, host, and environmental factors shape genotypes and subgenotypes. Infect Genet Evol. 2011;11(6):1199–207. doi:10.1016/j.meegid.2011.04.017.
Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE, Snowball MM, Cagle HH, Williams JL, Chulanov VP. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 2007;195(1):5–11. doi:10.1086/509894.
Pezzano SC, Torres C, Fainboim HA, Bouzas MB, Schroder T, Giuliano SF, Paz S, Alvarez E, Campos RH, Mbayed VA. Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect. 2011;17(2):223–31. doi:10.1111/j.1469-0691.2010.03283.x.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zehender, G., Ebranati, E., Fiaschi, L., Ciccozzi, M., Galli, M. (2016). HBV Virus in the Future. In: Borini, A., Savasi, M. (eds) Assisted Reproductive Technologies and Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-30112-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-30112-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30110-5
Online ISBN: 978-3-319-30112-9
eBook Packages: MedicineMedicine (R0)